These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6808980)

  • 1. Oral and topical treatment of experimental herpes simplex iritis with bromovinyldeoxyuridine.
    Maudgal PC; Uyttebroeck W; De Clercq E; Missotten L
    Arch Ophthalmol; 1982 Aug; 100(8):1337-40. PubMed ID: 6808980
    [No Abstract]   [Full Text] [Related]  

  • 2. Experimental stroma herpes simplex keratitis. Influence of treatment with topical bromovinyldeoxyuridine and trifluridine.
    Maudgal PC; De Clercq E; Descamps J; Missotten L; Wijnhoven J
    Arch Ophthalmol; 1982 Apr; 100(4):653-6. PubMed ID: 6803747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular penetration and efficacy of chloroethyldeoxyuridine against herpetic keratouveitis.
    Maudgal PC; De Clercq E; Bernaerts R; Dieltiens M; Breemersch M; Van Eeckhoutte L
    Invest Ophthalmol Vis Sci; 1986 Oct; 27(10):1453-8. PubMed ID: 3759363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of bromovinyldeoxyuridine-related compounds in the treatment of experimental herpes simplex keratitis.
    Maudgal PC; De Clercq E
    Arch Ophthalmol; 1985 Sep; 103(9):1393-7. PubMed ID: 4038133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of topical acyclovir therapy on experimental herpes simplex keratouveitis.
    Maudgal PC; Vrijghem JC; Molemans M; Missotten L
    Arch Ophthalmol; 1985 Sep; 103(9):1389-92. PubMed ID: 3929753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corneal epithelial dysplasia after trifluridine use.
    Maudgal PC; Van Damme B; Missotten L
    Graefes Arch Clin Exp Ophthalmol; 1983; 220(1):6-12. PubMed ID: 6403411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trifluorothymidine treatment of herpetic iritis in rabbits and ocular penetration.
    Sugar J; Varnell E; Centifanto Y; Kaufman HE
    Invest Ophthalmol; 1973 Jul; 12(7):532-4. PubMed ID: 4742994
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative antiviral efficacies of cidofovir, trifluridine, and acyclovir in the HSV-1 rabbit keratitis model.
    Romanowski EG; Bartels SP; Gordon YJ
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):378-84. PubMed ID: 9950596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPMPC, a broad-spectrum topical antiviral agent, inhibits herpes simplex virus type 1 replication and promotes healing of dendritic keratitis in the New Zealand rabbit ocular model.
    Gordon YJ; Romanowski EG; Araullo-Cruz T
    Cornea; 1994 Nov; 13(6):516-20. PubMed ID: 7842711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chemotherapeutic activity of bonafton in experimental herpetic keratitis in rabbits].
    Bogdanova NS; Nikolaeva IS; Pershin GN
    Farmakol Toksikol; 1975; 38(6):728-32. PubMed ID: 1227924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenine arabinoside therapy in corneal stromal disease and iritis due to herpes simplex.
    Brightbill FS; Kaufman HE
    Ann Ophthalmol; 1974 Jan; 6(1):25-32. PubMed ID: 4359979
    [No Abstract]   [Full Text] [Related]  

  • 12. Systemic therapy of ocular herpes.
    Kaufman HE
    Int Ophthalmol Clin; 1975; 15(4):163-9. PubMed ID: 818046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [BVDU therapy in herpes corneae].
    Benad A; Richter E
    Klin Monbl Augenheilkd; 1989 Jun; 194(6):424-6. PubMed ID: 2761189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental thymidine kinase-deficient HSV-1 keratitis: therapeutic attempts.
    Maudgal PC; De Clercq E; Huyghe P
    Curr Eye Res; 1987 Apr; 6(4):579-84. PubMed ID: 2953558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of bromovinyldeoxyuridine in the treatment of herpes simplex virus and varicella-zoster virus eye infections.
    Maudgal PC; De Clercq E; Missotten L
    Antiviral Res; 1984 Oct; 4(5):281-91. PubMed ID: 6335020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral drops: comparative therapy of experimental herpes simplex keratouveitis.
    Pavan-Langston D; Lass J; Campbell R
    Arch Ophthalmol; 1979 Jun; 97(6):1132-5. PubMed ID: 109070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of BVDU ((E)-5-(2-bromovinyl)-2'-deoxyuridine) in the treatment of experimental herpes simplex keratitis in rabbits.
    Maudgal PC; De Clercq E; Descamps J; Missotten L
    Bull Soc Belge Ophtalmol; 1979; 186():109-18. PubMed ID: 554711
    [No Abstract]   [Full Text] [Related]  

  • 18. (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine in the therapy of thymidine kinase-positive and -deficient herpes simplex virus experimental keratitis.
    Maudgal PC; De Clercq E
    Invest Ophthalmol Vis Sci; 1991 May; 32(6):1816-20. PubMed ID: 1851733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ac2IDU, BVDU, and thymine arabinoside therapy in experimental herpes keratitis.
    Hettinger ME; Pavan-Langston D; Park NH; Albert DM; De Clercq E; Lin TS
    Arch Ophthalmol; 1981 Sep; 99(9):1618-21. PubMed ID: 7283815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bromovinyldeoxyuridine treatment of herpetic keratitis clinically resistant to other antiviral agents.
    Maudgal PC; De Clercq E
    Curr Eye Res; 1991; 10 Suppl():193-9. PubMed ID: 1650667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.